Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
unclassifiableEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used